Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2019

Open Access 01-12-2019 | Rectal Cancer | Case report

Development of metachronous rectal cancers in a young man with dyskeratosis congenita: a case report

Authors: Motoko Watanabe, Gou Yamamoto, Kenji Fujiyoshi, Yoshito Akagi, Miho Kakuta, Yoji Nishimura, Kiwamu Akagi

Published in: Journal of Medical Case Reports | Issue 1/2019

Login to get access

Abstract

Background

DKC1 (dyskerin pseudouridine synthase 1) is a causative gene for X-linked dyskeratosis congenita. Approximately 8% of patients with dyskeratosis congenita have malignancy, but information about the development of malignancy in patients with dyskeratosis congenita is limited.

Case presentation

A young Japanese patient with bone marrow failure developed metachronous rectal adenocarcinomas at the ages of 16 and 18 years. He had no family history of cancer. Microsatellite instability testing with rectal tumor tissue demonstrated low-level microsatellite instability. To clarify whether any cancer susceptibility genes were involved in the development of rectal cancer, RNA sequencing was performed. Cancer-related genes were assessed, and a c.361A>G (p.Ser121Gly) germline variant was detected in DKC1. The same missense variant was previously reported in two patients with dyskeratosis congenita as a pathogenic variant, but those patients did not develop malignancies.

Conclusions

Our patient developed rectal cancer at an early age of onset compared with the previously reported typical onset age of patients with dyskeratosis congenita. DKC1 might be involved in predisposition to colorectal cancer in young adulthood; therefore, appropriate surveillance may be considered.
Literature
1.
go back to reference Zinsser F. Atrophia cutis reticularis cum pigmentatione dystrophia unguium et leukoplakia oris. Ikonogr Dermal Kioto. 1910;5:219–23. Zinsser F. Atrophia cutis reticularis cum pigmentatione dystrophia unguium et leukoplakia oris. Ikonogr Dermal Kioto. 1910;5:219–23.
2.
go back to reference Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med. 2010;12:753–64.CrossRef Savage SA, Bertuch AA. The genetics and clinical manifestations of telomere biology disorders. Genet Med. 2010;12:753–64.CrossRef
3.
go back to reference Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768–79.CrossRef Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768–79.CrossRef
4.
go back to reference Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009;145:164–72.CrossRef Walne AJ, Dokal I. Advances in the understanding of dyskeratosis congenita. Br J Haematol. 2009;145:164–72.CrossRef
5.
go back to reference Nishio N, Kojima S. Recent progress in dyskeratosis congenita. Int J Hematol. 2010;92:419–24.CrossRef Nishio N, Kojima S. Recent progress in dyskeratosis congenita. Int J Hematol. 2010;92:419–24.CrossRef
6.
go back to reference Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551–5.CrossRef Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 1999;402:551–5.CrossRef
7.
go back to reference Vulliamy TJ, Knight SW, Mason PJ, et al. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cell Mol Dis. 2001;27:353–7.CrossRef Vulliamy TJ, Knight SW, Mason PJ, et al. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cell Mol Dis. 2001;27:353–7.CrossRef
8.
go back to reference Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32–8.CrossRef Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet. 1998;19:32–8.CrossRef
9.
go back to reference Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet. 1999;65:50–8.CrossRef Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet. 1999;65:50–8.CrossRef
10.
go back to reference Kanegane H, Kasahara Y, Okamura J, et al. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br J Haematol. 2005;129:432–4.CrossRef Kanegane H, Kasahara Y, Okamura J, et al. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br J Haematol. 2005;129:432–4.CrossRef
11.
go back to reference McGrath JA. Dyskeratosis congenita: new clinical and molecular insights into ribosome function. Lancet. 1999;353:1204–5.CrossRef McGrath JA. Dyskeratosis congenita: new clinical and molecular insights into ribosome function. Lancet. 1999;353:1204–5.CrossRef
12.
go back to reference Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A. 2004;101:10756–61.CrossRef Mochizuki Y, He J, Kulkarni S, Bessler M, Mason PJ. Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Proc Natl Acad Sci U S A. 2004;101:10756–61.CrossRef
13.
go back to reference Alter BP, Giri N, Savage SA, Philip S, Rosenberg S. Cancer in dyskeratosis congenita. Blood. 2009;25:6549–57.CrossRef Alter BP, Giri N, Savage SA, Philip S, Rosenberg S. Cancer in dyskeratosis congenita. Blood. 2009;25:6549–57.CrossRef
14.
go back to reference Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenital gene, DKC1. Br J Haematol. 1999;107:335–9.CrossRef Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenital gene, DKC1. Br J Haematol. 1999;107:335–9.CrossRef
15.
go back to reference Aalfs CM, Berg HVD, Barth PG, Hennekam RCM. The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia. Eur J Pediatr. 1995;154:304–8.CrossRef Aalfs CM, Berg HVD, Barth PG, Hennekam RCM. The Hoyeraal-Hreidarsson syndrome: the fourth case of a separate entity with prenatal growth retardation, progressive pancytopenia and cerebellar hypoplasia. Eur J Pediatr. 1995;154:304–8.CrossRef
16.
go back to reference Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet. 2001;108:299–303.CrossRef Knight SW, Vulliamy TJ, Morgan B, Devriendt K, Mason PJ, Dokal I. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet. 2001;108:299–303.CrossRef
17.
go back to reference Vulliamy T, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutation in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107:2680–5.CrossRef Vulliamy T, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutation in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107:2680–5.CrossRef
18.
go back to reference Kawaguchi K, Sakamaki H, Onozawa Y, et al. Dyskeratosis congenita (Zinsser-Cole-Engman syndrome): an autopsy case presenting with rectal carcinoma, non-cirrhotic portal hypertension, and Pneumocystis carinii pneumonia. Virchows Arch A Pathol Anat Histopathol. 1990;417:247–53.CrossRef Kawaguchi K, Sakamaki H, Onozawa Y, et al. Dyskeratosis congenita (Zinsser-Cole-Engman syndrome): an autopsy case presenting with rectal carcinoma, non-cirrhotic portal hypertension, and Pneumocystis carinii pneumonia. Virchows Arch A Pathol Anat Histopathol. 1990;417:247–53.CrossRef
19.
go back to reference Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003;299:259–62.CrossRef Ruggero D, Grisendi S, Piazza F, et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science. 2003;299:259–62.CrossRef
20.
go back to reference Montanaro L, Brigotti M, Clohessy J, et al. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol. 2006;210:10–8.CrossRef Montanaro L, Brigotti M, Clohessy J, et al. Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer. J Pathol. 2006;210:10–8.CrossRef
Metadata
Title
Development of metachronous rectal cancers in a young man with dyskeratosis congenita: a case report
Authors
Motoko Watanabe
Gou Yamamoto
Kenji Fujiyoshi
Yoshito Akagi
Miho Kakuta
Yoji Nishimura
Kiwamu Akagi
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2019
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-019-2044-5

Other articles of this Issue 1/2019

Journal of Medical Case Reports 1/2019 Go to the issue